[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Unipharm AD Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Unipharm AD Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Unisplendour Guhan Group Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Unisplendour Guhan Group Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

United Gene High-Tech Group Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

United Gene High-Tech Group Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

United Therapeutics Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

United Therapeutics Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

University Health Industries, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

University Health Industries, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Unjha Formulations Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Unjha Formulations Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Upstream Biosciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Upstream Biosciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Urigen Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Urigen Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

US BioTec, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

US BioTec, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Valeant Pharmaceuticals International, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Valeant Pharmaceuticals International, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

ValiRX PLC. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ValiRX PLC. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vanda Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vanda Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vardhaman Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vardhaman Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vectura Group plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vectura Group plc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Velcera Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Velcera Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Venkat Pharma Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Venkat Pharma Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Venmax Drugs And Pharmaceuticals Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Venmax Drugs And Pharmaceuticals Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Ventana Biotech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ventana Biotech, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Venturepharm Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Venturepharm Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Venus Remedies Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Venus Remedies Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vernalis plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vernalis plc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Verona Pharma plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Verona Pharma plc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Veropharm Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Veropharm Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vertex Pharmaceuticals Incorporated Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vertex Pharmaceuticals Incorporated Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vertical Health Solutions Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vertical Health Solutions Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vetoquinol SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vetoquinol SA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

VIA Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

VIA Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vical Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vical Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vida Life International Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vida Life International Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vimta Labs Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vimta Labs Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vindon Healthcare Plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vindon Healthcare Plc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

VioQuest Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

VioQuest Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Viral Genetics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Viral Genetics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Viralytics Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Viralytics Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Prescient Therapeutics Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Prescient Therapeutics Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Virbac SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Virbac SA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

ViroMed Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ViroMed Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

ViroPharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ViroPharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Viropro Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Viropro Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

VirtualScopics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

VirtualScopics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vista Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vista Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vita Life Sciences Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vita Life Sciences Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vital Group Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vital Group Holdings Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vitro Diagnostics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vitro Diagnostics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vitrolife Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vitrolife Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Viva China Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Viva China Holdings Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vivakor, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vivakor, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Vivalis SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vivalis SA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

VIVUS Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

VIVUS Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

VMT Scientific Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

VMT Scientific Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers